Abstract

BackgroundRivaroxaban is an oral, direct Factor Xa inhibitor approved for clinical use for the prevention and treatment of thromboembolic disorders across several indications. Routine coagulation monitoring is not required, but...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Evaluation of the Anti-Factor Xa Chromogenic Assay for Measuring Rivaroxaban Plasma Concentrations Using Calibrators and Controls
Meyer Michel Samama ... Jean Luc Martinoli
Blood | VOL. 116
Meyer Michel Samama, et. al.Meyer Michel Samama ... Jean Luc Martinoli
19 Nov 2010
Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls
Theodore Spiro ... Meyer Samama
Thrombosis and haemostasis | VOL. 107
Theodore Spiro, et. al.Theodore Spiro ... Meyer Samama
01 Jan 2012
Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls
M Samama ... Y Gourmelin
European Journal of Hospital Pharmacy: Science and Practice | VOL. 19
M Samama, et. al.M Samama ... Y Gourmelin
01 Apr 2012
Validation of a Modified Anti-FXa Assay on STA-Compact Analyzer for Measuring FXa Inhibitor Levels in the Presence of Andexanet Alfa
Juan Cardenas ... Lisa K Jennings
Blood | VOL. 136
Juan Cardenas, et. al.Juan Cardenas ... Lisa K Jennings
05 Nov 2020
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
A single harmonised pharmacy process to improve clinical trial set-up times
Miriam Lettieri ... Beatriz Duran Jimenez
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Miriam Lettieri, et. al.Miriam Lettieri ... Beatriz Duran Jimenez
27 Jun 2024
Potential medicine waste in the process of outpatients receiving cost-free medicines from medicine pick-up lockers in the North Denmark region
Lisa Greve Routhe ... Anne Estrup Olesen
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Lisa Greve Routhe, et. al.Lisa Greve Routhe ... Anne Estrup Olesen
26 Jun 2024
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients
Yan Yan ... Ji Wu
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Yan Yan, et. al.Yan Yan ... Ji Wu
19 Jun 2024
Harm to a child caused by the off-label use of prochlorperazine maleate tablets due to the discontinuation of licensed prochlorperazine mesilate liquid in the UK
Stephen Morris ... Andrew Salm
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Stephen Morris, et. al.Stephen Morris ... Andrew Salm
14 Jun 2024
View more papers